ABILIV
Dead / Abandoned — Abandoned — failure to respond (as of 16 Oct 2024)
What this means for you
This application is over — abandoned 30 Sept 2024. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 98266390
- Mark type
- Stylized text
- Filed
- 12 Nov 2023
- Abandoned
- 30 Sept 2024
- Attorney of record
- Yue (Robert) Xu
Goods and services
- Class 005 — Pharmaceuticals: Medicines for human purposes, namely, medicinal preparations for the treatment of cancer; Capsules for medicines, namely, coated capsule medicines for prevention and treatment of human diseases, namely, anti-tumor purposes; Pharmaceutical preparations for suppressing tumors; Chemico-pharmaceutical preparations, namely, chemical preparations for pharmaceutical or medical purposes, namely, for use in the treatment of cancer; Drugs for medical purposes, namely, pharmaceutical preparations for the prevention and treatment of cancer; Biological preparations for medical purposes, namely, biological preparations for the treatment of cancer; Chemical preparations for medical and pharmaceutical use for treating oncological diseases, namely, liver cancer; Pharmaceutical preparations in the form of injections for tumor suppression; Raw material drugs, namely, pharmaceuticals for anti-tumor treatment; Pharmaceutical preparations for human biomedicine, namely, cancer therapy
Owner
- Abbisko Therapeutics Co., Ltd., Shanghai, CN
Prosecution history
- 16 Oct 2024 — ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND
- 16 Oct 2024 — ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
- 27 Jun 2024 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 27 Jun 2024 — NON-FINAL ACTION E-MAILED
- 27 Jun 2024 — NON-FINAL ACTION WRITTEN
- 19 Jun 2024 — ASSIGNED TO EXAMINER
- 14 Dec 2023 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
- 15 Nov 2023 — NEW APPLICATION ENTERED